OrthoTrophix, Inc.
PrivateLast Round
VC Round
Dec 16, 2016
Company Overview
OrthoTrophix, Inc. is a biopharmaceutical company that develops and commercializes disease-modifying osteoarthritis drugs and therapies for hard tissue conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OrthoTrophix, Inc. Comparables
Compare OrthoTrophix, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genascence Corporation | 86% | |
| Cytonics Corporation | 86% | |
| Amplicore Inc. | 83% | |
OrthoTrophix, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 16, 2016 | ||||
| Series A | Jan 1, 2014 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 16, 2016
Completed a VC Round funding round.
- Jan 1, 2014
Completed a Series A funding round.
OrthoTrophix, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about OrthoTrophix, Inc.'s valuation, stock price, and market status.